Results 131 to 140 of about 11,052,815 (324)

Strength through diversity: how cancers thrive when clones cooperate

Molecular Oncology, EarlyView.
Intratumor heterogeneity can offer direct benefits to the tumor through cooperation between different clones. In this review, Kuiken et al. discuss existing evidence for clonal cooperativity to identify overarching principles, and highlight how novel technological developments could address remaining open questions.
Marije C. Kuiken, Maartje Witsen, Emile E. Voest, Krijn K. Dijkstra   +3 more
wiley   +1 more source

Towards a National Collection: Persistent Identifiers as IRO Infrastructure – Project Launch Webinar

, 2020
Rachael Kotarski, Joseph Padfield, John D. Stack, Frances Madden   +3 more
openalex   +1 more source

Persistent Identifiers and VIVO

, 2016
Presented at the 2016 VIVO Conference, Denver ...
openaire   +1 more source

Detection of circulating tumor DNA in colorectal cancer patients using a methylation‐specific droplet digital PCR multiplex

Molecular Oncology, EarlyView.
We developed a cost‐effective methylation‐specific droplet digital PCR multiplex assay containing tissue‐conserved and tumor‐specific methylation markers. The assay can detect circulating tumor DNA with high accuracy in patients with localized and metastatic colorectal cancer.
Luisa Matos do Canto, Louise Raunkilde, Jan Lindebjerg, Mads Malik Aagaard, Christina Therkildsen, Jakob Kleif, Lars Henrik Jensen, Torben Frøstrup Hansen, Rikke Fredslund Andersen   +8 more
wiley   +1 more source

A blockchain based Trusted Persistent Identifier system for Big Data in Science

Foundations of Computing and Decision Sciences, 2019
A stable reference of Internet resources is crucial not only to identify a resource in a trustworthy and certified way but also to guarantee continuous access to it over time.
Bellini Emanuele
doaj   +1 more source

CESSDA ERIC Persistent Identifier Policy

, 2017
"The CESSDA ERIC Persistent Identifier Policy is intended to support the aims of locating, discovering, referencing, identifying and citing CESSDA SP data holdings. It serves as a basis for a common approach to the use of Persistent Identifier services across the CESSDA SP. The policy contains requirements regarding the use of Persistent Identifiers to
Hausstein, Brigitte, Borschewski, Kerrin, Jerlehag, Birger, van Horik, René, van der Vaart, Lilian   +4 more
openaire   +1 more source

Perspectives in educating molecular pathologists on liquid biopsy: Toward integrative, equitable, and decentralized precision oncology

Molecular Oncology, EarlyView.
Liquid biopsy enables minimally invasive, real‐time molecular profiling through analysis of circulating biomarkers in biological fluids. This Perspective highlights the importance of training pathologists through integrative educational programs, such as the European Masters in Molecular Pathology, to ensure effective and equitable implementation of ...
Marius Ilié, Umberto Malapelle, Catherine Alix‐Panabières, Claus Lindbjerg Andersen, Sandra Chlebowski, Vivien Lake, Caroline Lacoux, Virginie Lespinet‐Fabre, Olivier Bordone, Simon Heeke, Christophe Bontoux, Ellen Heitzer, Klaus Pantel, Paul Hofman   +13 more
wiley   +1 more source

AB1474 LIPIDOMIC PROFILING IDENTIFIES SERUM LIPIDS ASSOCIATED WITH PERSISTENT MULTISITE MUSCULOSKELETAL PAIN [PDF]

, 2022
Canchen Ma, M. Liu, Jing Tian, Guangju Zhai, Flavia Cicuttini, Yvette L. Schooneveldt, Peter J. Meikle, Graeme Jones, Feng Pan   +8 more
openalex   +1 more source

Persistent Identifiers In The Life Sciences

, 2017
Introduction to EMBL-EBI, integration of Persistent Identifiers in the life sciences information services, and the institution's cooperative efforts with project THOR and OpenAIRE.
openaire   +1 more source

Potential therapeutic targeting of BKCa channels in glioblastoma treatment

Molecular Oncology, EarlyView.
This review summarizes current insights into the role of BKCa and mitoBKCa channels in glioblastoma biology, their potential classification as oncochannels, and the emerging pharmacological strategies targeting these channels, emphasizing the translational challenges in developing BKCa‐directed therapies for glioblastoma treatment.
Kamila Maliszewska‐Olejniczak, Karolina Pytlak, Sandra Jaworowska, Bogusz Kulawiak, Piotr Bednarczyk   +4 more
wiley   +1 more source